Home » Topics » BioWorld

BioWorld
RSS

DNX, GENPHARM SIGN CROSS-LICENSE

Jan. 10, 1991

ECOGEN SIGNS R AND D DEAL WITH ROUSSEL

Jan. 10, 1991

HAMBRECHT AND QUIST CONFERENCE

Jan. 10, 1991

APPOINTMENTS AND ADVANCEMENTS

Jan. 9, 1991

NEWS BRIEFS

Jan. 9, 1991

H AND Q CONFERENCE BRIEFS

Jan. 9, 1991

DU PONT MERCK DRUG GETS GO-AHEAD

Jan. 9, 1991

CHIRON PREDICTS $160 MILLION IN REVENUES

Jan. 9, 1991

DU PONT CLAIMS CETUS 'REDISCOVERED' PCR

Jan. 9, 1991

ADVANCEMENTS AND APPOINTMENTS

Jan. 8, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...